MRSA 검사 시장 규모, 점유율, 성장 분석 : 제품 유형별, 검사 유형별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global MRSA Testing Market size was valued at USD 4.68 Billion in 2024 and is poised to grow from USD 4.88 Billion in 2025 to USD 6.73 Billion by 2033, growing at a CAGR of 4.1% during the forecast period (2026-2033).

The global MRSA testing market is witnessing substantial growth, driven by the healthcare sector's urgent focus on the rapid identification and management of antibiotic-resistant infections. Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health challenge, particularly as it contributes to hospital-acquired infections while resisting multiple antibiotics. The rising incidence of MRSA infections across community and healthcare environments has significantly heightened the demand for accurate and timely diagnostics. Enhanced infection control measures in hospitals and outpatient facilities are crucial market catalysts. Additionally, advancements in point-of-care testing, molecular diagnostics, and automated platforms facilitate quicker and more precise detection of MRSA. Increased awareness and regulatory mandates for routine screenings further boost market dynamics, ensuring MRSA testing's vital role in global infection control strategies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global MRSA Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global MRSA Testing Market Segments Analysis

Global MRSA Testing Market is segmented by Product Type, Test Type, End user and region. Based on Product Type, the market is segmented into Instruments and Reagents & Kits. Based on Test Type, the market is segmented into Immunodiagnostic Test and Molecular Diagnostic Test. Based on End user, the market is segmented into Hospitals, Diagnostic Laboratories and Academic and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global MRSA Testing Market

The increasing prevalence of antibiotic-resistant bacteria, particularly MRSA and VRSA, is leading to a surge in hospital-acquired infections, particularly in high-risk environments such as intensive care units and dialysis centers. Factors such as prolonged hospital stays and the occurrence of invasive medical procedures further exacerbate the situation. This scenario underscores the urgent need for improved infection control strategies, as evidenced by concerning statistics on MRSA colonization released by various health organizations. The focus on enhancing diagnostic and testing capabilities in the market is driven by the necessity to combat these resilient pathogens effectively and safeguard patient health.

Restraints in the Global MRSA Testing Market

The global MRSA testing market faces various limitations, primarily due to the critical implications of MRSA for patient safety, particularly among vulnerable groups reliant on healthcare services. The transmission of MRSA occurs both via direct contact and through the use of medical devices. Moreover, sectors beyond healthcare, including telecommunications and electronics, experience contamination risks during processes like surface-mount technology (SMT) and printed circuit board (PCB) assembly. This highlights a pressing need for effective infection prevention measures across all industries, underscoring the complexity and challenges in addressing MRSA control in diverse environments.

Market Trends of the Global MRSA Testing Market

The Global MRSA Testing market is currently experiencing a significant trend towards the integration of AI-powered diagnostic platforms. This innovation is transforming traditional diagnostic workflows by automating result interpretation and expediting image analysis, which in turn enhances detection accuracy. The implementation of AI technologies is not only minimizing turnaround times but also boosting laboratory efficiency, making it possible for healthcare providers to implement earlier infection control measures, particularly in high-risk environments. As the demand for rapid and precise MRSA testing grows, the adoption of these advanced tools is expected to play a pivotal role in shaping the future landscape of infectious disease management.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Analysis

Global MRSA Testing Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Instruments
• Reagents & Kits

Global MRSA Testing Market Size by Test Type & CAGR (2026-2033)

• Market Overview
• Immunodiagnostic Test
• Molecular Diagnostic Test

Global MRSA Testing Market Size by End user & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Academic and Research Institutes

Global MRSA Testing Market Size & CAGR (2026-2033)

• North America (Product Type, Test Type, End user)
  • US
  • Canada
• Europe (Product Type, Test Type, End user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Test Type, End user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Test Type, End user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Test Type, End user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• 3M Co.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ALIFAX Srl
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arlington Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton Dickinson and Co.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio Rad Laboratories Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corp.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corp.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin Spa
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann La Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GENSPEED Biotech GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OpGen Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Puritan Medical Products Co.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• R Biopharm AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sekisui Diagnostics LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Uniogen Oy
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZeptoMetrix LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations